Life Science News

RSS

Thermo Fisher Scientific announces final results of its 2.50% Convertible Senior Notes offer

Thermo Fisher Scientific Inc. announced today the expiration and final results of the company’s previously announced tender offer (the “Offer”) to purchase for cash any and all of its outstanding 2.50% Convertible Senior Notes due 2023 (the “Convertible Notes”). The Offer expired at 12:00 midnight, New York City time, at the end of Thursday, December 17, 2009.

From Thermo Fisher Scientific Inc. 19 Dec 2009

Roche Diagnostics and Takara Bio enter into license agreement

Roche Diagnostics and Takara Bio, the Shiga (Japan)-based supplier of systems for use in life science research, announced that they have entered into a license agreement for use of the melting curve analysis technology and SYBR Green techniques in their Kits and Instruments for Real Time PCR.

From Roche Sequencing and Life Science 18 Dec 2009

Thermo Fisher Scientific selected as NCS biological and environmental sample repository partner

Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has been selected as the National Children’s Study (NCS) biological and environmental sample repository partner. The study examines the effects of environmental influences on the health and development of 100,000 children across the United States, following them from before birth until age 21.

From Thermo Fisher Scientific Inc. 17 Dec 2009

MDS served with a Notice of Application

MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it was served with a Notice of Application (the "Notice") from PerkinElmer, Inc., with whom MDS has a joint-venture to develop, manufacture and sell inductively coupled plasma mass spectrometers (ICP/MS).

From PerkinElmer 14 Dec 2009

Roche Diagnostics launches new customer training center in Pleasanton, California

Roche Diagnostics announced today the opening of a new west-coast customer training center in Pleasanton, California, as part of an initiative to make state-of-the-art training on diagnostic equipment more accessible to hospitals and independent laboratories on the west and east coasts.

From Roche Sequencing and Life Science 8 Dec 2009

PerkinElmer introduces new tools to improve life sciences research

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a wide range of new tools to improve the speed and effectiveness of life sciences research.

From PerkinElmer 5 Dec 2009

Fluxion Biosciences signs distribution agreement with DI Biotech and Novel Science

Fluxion Biosciences announced today that it has expanded its sales and service network into Asia. The company signed a distribution agreement for its BioFlux™ line with Korea-based DI Biotech. A second agreement with Novel Science covers sales of both the BioFlux and IonFlux™ platforms in Japan. Fluxion has also sold its first BioFlux 1000 system into China.

From Fluxion Biosciences 4 Dec 2009

FDA approves additional intended use of Roche's cobas TaqScreen MPX Test

Roche announced today that the United States Food & Drug Administration (FDA) approved an additional intended use for its licensed nucleic acid test, to screen source plasma in pools comprised of up to 96 individual donations. The test, called the cobas® TaqScreen MPX Test for use on the cobas s 201 system, is a qualitative, in-vitro test for the simultaneous, direct detection of the human immunodeficiency virus (HIV-1 Group M RNA, HIV-1 Group O RNA , HIV-2 RNA), hepatitis C virus RNA and hepatitis B virus DNA in human plasma.

From Roche Sequencing and Life Science 2 Dec 2009

Roche, Spanish Department of Health to collaborate in Medical Genome Project

Roche and the Department of Health of Junta de Andalucía, Spain have signed an agreement for a cooperation in the Medical Genome Project (MGP), a research project created to analyse the genomes of people with rare diseases and identify the defective gene or genes causing the disease and its behaviour.

From Roche Sequencing and Life Science 24 Nov 2009

Image of a water flea wins top prize in the 2009 Olympus BioScapes Digital Imaging Competition

A glowing, eerily beautiful image of a water flea with its radiant green "crown of thorns" took top prize in the 2009 Olympus BioScapes Digital Imaging Competition®, the world's foremost forum for showcasing microscope photos and movies of life science subjects. Dr. Jan Michels, a zoologist at the University of Albrecht, Kiel, Germany, took top honors for the image of a water flea, with its defensive "crown of thorns" to protect it against predators. The image reveals not only the exoskeleton, but also interior detail down to the nuclei within its cells, seen as tiny, glowing blue dots. This

From Evident Corporation 20 Nov 2009

PerkinElmer and Gilson announce MS collaboration to support pharmaceutical and biotech scientists

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, and Gilson, Inc., an industry leader in purification systems for liquid chromatography (LC) and solid phase extraction (SPE), today announced a mass spectroscopy (MS) collaboration to support pharmaceutical and biotech scientists.

From PerkinElmer 19 Nov 2009

NRC helps Olympus to design and commercialize CARS microscope

The National Research Council Canada (NRC) recently helped Olympus, a world leader in advanced optical microscopy and medical imaging, to design and commercialize a CARS (Coherent Anti-stokes Raman Scattering) microscope.

From Evident Corporation 16 Nov 2009

New microplate for BioFlux live cell imaging workstations

Fluxion Biosciences introduces a new microplate for its BioFlux live cell imaging workstations, extending their shear flow limits to simulate a variety of pathological vascular conditions. With the new High Shear Plate, the BioFlux systems can be an effective tool in thrombosis and platelet studies, cardiovascular and immunological drug screening and cell/bacteria adhesion research.

From Fluxion Biosciences 11 Nov 2009

World's smallest gastrointestinal videoscope with four-way angulation and NBI

Olympus today introduced the world's smallest gastrointestinal videoscope to offer four-way angulation and Narrow Band Imaging™ (NBI) to detect upper gastrointestinal abnormalities. The super-slim scope is 5.5 mm in diameter at the distal end, as well as the insertion tube, and offers exceptional insertion capability to enhance patient comfort. The scope also features NBI, Olympus' proprietary imaging technology that filters white light to consist of specific wavelength bands enabling enhanced observation of microvessels and subtle changes on the mucosa.

From Evident Corporation 11 Nov 2009

Olympus Medical Systems and Opitz + Flierl Hospitaltechnik offer complete integrated solutions for operating theatres

Under the leadership of its Systems Integration business unit, Olympus Medical Systems Europa GmbH, Hamburg, together with Opitz + Flierl Hospitaltechnik AG, Heideck near Nuremberg, Germany, have agreed a joint venture to meet the technological challenges of constructing hospital interiors for the future, whilst expanding their positions in the market.

From Evident Corporation 9 Nov 2009

$1.85 million grant to study how digital games can improve players' health behaviors and outcomes

The Robert Wood Johnson Foundation (RWJF) today announced more than $1.85 million in grants for research that will offer unprecedented insight into how digital games can improve players' health behaviors and outcomes. With funding from RWJF's Health Games Research national program, nine research teams across the country will conduct extensive studies to discover, for example, how the popular dance pad video game Dance Dance Revolution might help Parkinson's patients reduce the risk of falling, how Wii Active might be most effectively implemented in high schools to help overweight students lose weight, how a mobile phone game with a breath interface might help smokers quit or reduce their tobacco use, or how facial recognition games might be designed to help people with autism learn to identify others' emotions.

From Evident Corporation 6 Nov 2009

PerkinElmer receives FDA clearance for its Genetic Screening Processor

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that the Company has received 510K clearance from the U.S. Food and Drug Administration for its GSP™ Genetic Screening Processor, which is used by public health laboratories worldwide as part of newborn screening programs.

From PerkinElmer 4 Nov 2009

PerkinElmer and Corning collaborate in development of label-free detection technologies

PerkinElmer Inc. and Corning Incorporated, today announced that the two companies have entered into a strategic agreement to advance the development of next-generation label-free detection technologies.

From PerkinElmer 28 Oct 2009

Thermo Fisher Scientific announces the availability of its Copeptin assay in Europe

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the availability in Europe of its new Copeptin assay, which helps medical personnel quickly and accurately diagnose acute myocardial infarction (AMI), commonly known as a heart attack.

From Thermo Fisher Scientific Inc. 26 Oct 2009

New nucleic acid test to screen donated blood for HIV-1 Group M RNA approved

Health Canada has approved a new nucleic acid test from Roche Diagnostics to screen donated blood for HIV-1 Group M RNA, hepatitis C RNA and hepatitis B DNA in a single, automated assay.

From Roche Sequencing and Life Science 24 Oct 2009